BD Strengthens Leadership in Peripheral Vascular Innovation with Positive AGILITY Trial Results

Nine-month follow-up data from an ongoing 36-month study showed high vessel patency, low reintervention rates, and meaningful improvements in mobility and symptoms among patients treated for complex iliac artery disease. The interim findings support the treatment, but the excerpt provides no numerical outcome rates or further study details.